OTCMKTS:CGNH - CardioGenics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.0145 0.00 (0.00 %)
(As of 06/24/2018 02:25 PM ET)
Previous Close$0.0145
Today's Range$0.0101 - $0.0145
52-Week Range$0.0034 - $0.0330
Volume8,000 shs
Average Volume67,872 shs
Market Capitalization$1.39 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

Receive CGNH News and Ratings via Email

Sign-up to receive the latest news and ratings for CGNH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:CGNH
CUSIPN/A
Phone905-673-8501

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares96,050,000

The Truth About Cryptocurrencies

CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions

What is CardioGenics' stock symbol?

CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."

Who are some of CardioGenics' key competitors?

Who are CardioGenics' key executives?

CardioGenics' management team includes the folowing people:
  • Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc., Chief Exec. Officer and Director (Age 60)
  • Mr. James A. Essex CA, MBA, Chief Financial Officer (Age 69)
  • Ms. Linda J. Stering F.Inst.L.C.O., Sec. and Director (Age 57)

Has CardioGenics been receiving favorable news coverage?

Media headlines about CGNH stock have been trending very positive on Sunday, according to Accern. The research firm scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CardioGenics earned a coverage optimism score of 0.70 on Accern's scale. They also assigned news coverage about the company an impact score of 43.66 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of CardioGenics?

Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CardioGenics' stock price today?

One share of CGNH stock can currently be purchased for approximately $0.0145.

How big of a company is CardioGenics?

CardioGenics has a market capitalization of $1.39 million.

How can I contact CardioGenics?

CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected]


MarketBeat Community Rating for CardioGenics (CGNH)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  57
MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe CGNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.